Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Progress on the proton-radius puzzle.

Karr JP, Marchand D.

Nature. 2019 Nov;575(7781):61-62. doi: 10.1038/d41586-019-03364-z. No abstract available.

PMID:
31695215
2.

Fundamental Transitions and Ionization Energies of the Hydrogen Molecular Ions with Few ppt Uncertainty.

Korobov VI, Hilico L, Karr JP.

Phys Rev Lett. 2017 Jun 9;118(23):233001. doi: 10.1103/PhysRevLett.118.233001. Epub 2017 Jun 8.

PMID:
28644635
3.

ATP Is an Allosteric Inhibitor of Coxsackievirus B3 Polymerase.

Karr JP, Peersen OB.

Biochemistry. 2016 Jul 19;55(28):3995-4002. doi: 10.1021/acs.biochem.6b00467. Epub 2016 Jul 6.

4.

Theoretical Hyperfine Structure of the Molecular Hydrogen Ion at the 1 ppm Level.

Korobov VI, Koelemeij JC, Hilico L, Karr JP.

Phys Rev Lett. 2016 Feb 5;116(5):053003. doi: 10.1103/PhysRevLett.116.053003. Epub 2016 Feb 2.

PMID:
26894709
5.

Probing QED and fundamental constants through laser spectroscopy of vibrational transitions in HD(.).

Biesheuvel J, Karr JP, Hilico L, Eikema KS, Ubachs W, Koelemeij JC.

Nat Commun. 2016 Jan 27;7:10385. doi: 10.1038/ncomms10385.

6.

mα(7)-order corrections in the hydrogen molecular ions and antiprotonic helium.

Korobov VI, Hilico L, Karr JP.

Phys Rev Lett. 2014 Mar 14;112(10):103003. Epub 2014 Mar 12.

PMID:
24679287
7.

Why three-body physics does not solve the proton-radius puzzle.

Karr JP, Hilico L.

Phys Rev Lett. 2012 Sep 7;109(10):103401. Epub 2012 Sep 7.

PMID:
23005286
8.

Note: a high transmission Faraday optical isolator in the 9.2 μm range.

Hilico L, Douillet A, Karr JP, Tournié E.

Rev Sci Instrum. 2011 Sep;82(9):096106. doi: 10.1063/1.3640004.

PMID:
21974633
9.

Interference of coherent polariton beams in microcavities: polarization-controlled optical gates.

Leyder C, Liew TC, Kavokin AV, Shelykh IA, Romanelli M, Karr JP, Giacobino E, Bramati A.

Phys Rev Lett. 2007 Nov 9;99(19):196402. Epub 2007 Nov 7.

PMID:
18233093
10.

Narrow-line phase-locked quantum cascade laser in the 9.2 microm range.

Bielsa F, Douillet A, Valenzuela T, Karr JP, Hilico L.

Opt Lett. 2007 Jun 15;32(12):1641-3.

PMID:
17572732
11.

Four wave mixing oscillation in a semiconductor microcavity: generation of two correlated polariton populations.

Romanelli M, Leyder C, Karr JP, Giacobino E, Bramati A.

Phys Rev Lett. 2007 Mar 9;98(10):106401. Epub 2007 Mar 7.

PMID:
17358552
12.

Quantum degeneracy of microcavity polaritons.

Baas A, Karr JP, Romanelli M, Bramati A, Giacobino E.

Phys Rev Lett. 2006 May 5;96(17):176401. Epub 2006 May 1.

PMID:
16712316
13.

Parametric polariton amplification in semiconductor microcavities.

Messin G, Karr JP, Baas A, Khitrova G, Houdré R, Stanley RP, Oesterle U, Giacobino E.

Phys Rev Lett. 2001 Sep 17;87(12):127403. Epub 2001 Aug 31.

PMID:
11580557
14.

A comparison of prostate cancer patients in Japan and the USA.

Imai K, Takahashi Y, Nakata S, Karr JP, Huben R.

Int J Urol. 1994 Sep;1(3):256-62.

15.

Pediatric home care--designing unique care for kids.

Karr JP, Locke PD, Leonard J.

Caring. 1993 Dec;12(12):4, 7-8, 10 passim.

PMID:
10130222
16.

Prostate cancer in the United States and Japan.

Karr JP.

Adv Exp Med Biol. 1992;324:17-28. Review. No abstract available.

PMID:
1492614
17.

A rational next step in the treatment of some rectal adenocarcinomas.

Steele G Jr, Hamilton JM, Karr JP.

J Clin Oncol. 1989 Aug;7(8):988-90. No abstract available. Erratum in: J Clin Oncol 1989 Nov;7(11):1757.

PMID:
2754452
18.

A uniform histopathologic grading system for prostate cancer. Subcommittee on Diagnostic Nomenclature, Prostate Cancer Working Group, Organ Systems Program.

Gardner WA Jr, Coffey D, Karr JP, Chiarodo A, Epstein J, McNeal JE, Miller G.

Hum Pathol. 1988 Jan;19(1):119-20. No abstract available.

PMID:
3335387
19.

Diagnostic nomenclature for prostate cancer.

Gardner WA Jr, Coffey D, Karr JP, Chiarodo A, Epstein J, McNeal JE, Miller G.

J Urol. 1987 Dec;138(6):1436. No abstract available.

PMID:
3682073
20.

Prostatic cancer nomenclature.

Gardner WA Jr, Coffey D, Karr JP, Chiarodo A, Epstein J, McNeal JE, Miller G.

Urology. 1987 Oct;30(4):404. No abstract available.

PMID:
3660535
21.

Nomenclature of prostatic carcinoma.

Gardner WA Jr, Coffey D, Karr JP, Chiarodo A, Epstein J, McNeal JE, Miller G.

Arch Pathol Lab Med. 1987 Oct;111(10):898. No abstract available.

PMID:
3632265
22.

The potential significance of aromatase in the etiology and treatment of prostatic disease.

Karr JP, Kaburagi Y, Mann CF, Sandberg AA.

Steroids. 1987 Oct-Dec;50(4-6):449-57. Review.

PMID:
3332935
23.

The possibility of aromatization of androgen in human prostate.

Kaburagi Y, Marino MB, Kirdani RY, Greco JP, Karr JP, Sandberg AA.

J Steroid Biochem. 1987 Jun;26(6):739-42.

PMID:
2441142
24.

Prostate metabolism of steroids following castration.

Karr JP, Drury R, Mann CF, Huben RP, Tubbs RR, Pontes JE, Sandberg AA.

Prog Clin Biol Res. 1987;243A:61-76. Review. No abstract available.

PMID:
3309975
25.

Estrogen and progestin receptors in human prostatic carcinoma.

Wolf RM, Schneider SL, Pontes JE, Englander L, Karr JP, Murphy GP, Sandberg AA.

Cancer. 1985 May 15;55(10):2477-81.

PMID:
3986743
26.

Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.

Kadohama N, Wakisaka M, Kim U, Karr JP, Murphy GP, Sandberg AA.

J Natl Cancer Inst. 1985 Feb;74(2):475-86.

PMID:
3856054
27.

Effects of vincristine versus vinblastine on clonogenic growth of human testicular tumor cells in soft agar.

Karr JP, Bulbul MA, Pavelic ZP, Pontes JE.

Prog Clin Biol Res. 1985;203:401-10. No abstract available.

PMID:
3832096
28.

The antigenic relatedness of proteins from human and simian prostate fluid.

Carter DB, Timmins JG, Adams LD, Lewis RW, Karr JP, Resnick MI, Buhl AE.

Prostate. 1985;6(4):395-402.

PMID:
2418427
29.

Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.

Kadohama N, Karr JP, Murphy GP, Sandberg AA.

Cancer Res. 1984 Nov;44(11):4947-54.

30.

Induction of benign prostatic hypertrophy in baboons.

Karr JP, Kim U, Resko JA, Schneider S, Chai LS, Murphy GP, Sandberg AA.

Urology. 1984 Mar;23(3):276-89.

PMID:
6199881
31.

In vivo assessment of urinary bladder malignancy.

Karr JP, Pontes JE, Murphy GP, Gibas Z, Sandberg AA.

Prog Clin Biol Res. 1984;162A:331-46. No abstract available.

PMID:
6592614
32.

Benign prostatic hyperplasia in the baboon.

Karr JP, Kim U, Murphy GP, Sandberg AA.

Prog Clin Biol Res. 1984;145:257-89. No abstract available.

PMID:
6201878
33.

Clinical aspects of steroid hormone receptors in human renal cell carcinoma.

Karr JP, Pontes JE, Schneider S, Sandberg AA, Murphy GP.

J Surg Oncol. 1983 Jun;23(2):117-24.

PMID:
6855241
34.

The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinoma.

Brown WJ, Karr JP, McGarry M, Williams PD, Hagerman LM, Murphy GP.

J Surg Oncol. 1983 Apr;22(4):273-7.

PMID:
6834849
35.

LNCaP model of human prostatic carcinoma.

Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP.

Cancer Res. 1983 Apr;43(4):1809-18.

36.

Effect of tamoxifen citrate on a murine renal cell adenocarcinoma.

Williams PD, Karr JP, Murphy GP.

Oncology. 1983;40(4):296-300.

PMID:
6866425
37.

Effects of estramustine and megestrol on ultrastructure of rat ventral prostate.

Dinchuk JE, Chai LS, Karr JP, Murphy GP, Sandberg AA.

Urology. 1982 May;19(5):511-22.

PMID:
7080325
38.

Estrogen receptors and clinical correlations with human prostatic disease.

Pontes JE, Karr JP, Kirdani RY, Murphy GP, Sandberg AA.

Urology. 1982 Apr;19(4):399-403.

PMID:
6176061
39.

Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response.

Pertschuk LP, Rosenthal HE, Macchia RJ, Eisenberg KB, Feldman JG, Wax SH, Kim DS, Whitmore WF Jr, Abrahams JI, Gaetjens E, Wise GJ, Herr HW, Karr JP, Murphy GP, Sandberg AA.

Cancer. 1982 Mar 1;49(5):984-93.

PMID:
7059932
40.

Receptor profiles in renal cell carcinoma.

Karr JP, Schneider S, Rosenthal H, Sandberg AA, Murphy GP.

Prog Clin Biol Res. 1982;100:211-44. No abstract available.

PMID:
7145947
41.

Effects of DES on the morphology of the lobes of the baboon prostate.

Chai LS, Karr JP, Murphy GP, Sandberg AA.

Invest Urol. 1981 Nov;19(3):202-8.

PMID:
7298293
42.

Estramustine binding in rat, baboon and human prostate measured by high pressure liquid chromatography.

Kirdani RY, Corrales JJ, Høisaeter PA, Karr JP, Murphy GP, Sandberg AA.

Steroids. 1981 May;37(5):471-84.

PMID:
7256814
43.

Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture.

Høisaeter PA, Kadohama N, Corrales JJ, Karr JP, Murphy GP, Sandberg AA.

J Steroid Biochem. 1981 Mar;14(3):251-60. No abstract available.

PMID:
7218791
44.

Use of silastic implants to raise plasma androgen levels in the immature baboon (Papio cynocephalus).

Kirdani RY, Wajsman Z, McGarry M, Karr JP, Sandberg AA, Murphy GP.

J Med Primatol. 1981;10(1):52-4.

PMID:
7277465
45.

Prostatic cancer: diagnosis and prognosis.

Karr JP, Slack NH, Murphy GP.

Compr Ther. 1980 Oct;6(10):34-41. No abstract available.

PMID:
7449363
46.
47.

Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.

Kirdani RY, Karr JP, Murphy GP, Sandberg AA.

N Y State J Med. 1980 Aug;80(9):1390-3. No abstract available.

PMID:
6938806
48.

An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma.

Slack NH, Karr JP, Chu TM, Murphy GP.

Prostate. 1980;1(2):259-70. Review.

PMID:
15619925
49.

Hormonal receptors in human neoplasia.

Sandberg AA, Karr JP.

Int Adv Surg Oncol. 1980;3:311-50. No abstract available.

PMID:
6256296
50.

Prostatic acid phosphatase - the developing experience.

Murphy GP, Chu TM, Karr JP.

Clin Biochem. 1979 Dec;12(6):226-7. No abstract available.

PMID:
535156

Supplemental Content

Support Center